Loading...
Loading...
Brain imaging shows real changes across the menopause transition, and most of them settle afterward. Hormone therapy's effect on memory and dementia has been tested in trials, and the answer is more modest than you may have heard.
You used to remember everything. Names, dates, where you put your keys, the thing you walked into the kitchen to get. Then one day the word you need in a meeting simply vanishes, you read the same paragraph three times, and you start to wonder, quietly, whether this is early dementia.
For most women it is not, and there is a way to tell the difference, covered below. Something real is happening in the brain during the menopause transition, and brain imaging now shows it at the group level. What that means for hormone therapy is a separate question, and it has been tested in randomized trials. This page covers both: what menopause does to the brain, and what HRT does and does not do to it, with the studies named so you can check them.
Disclaimer: This article is for informational purposes only and is not medical advice. If you are experiencing cognitive changes, please consult a qualified healthcare provider about your individual situation.
Start HRT online with Gala Health
Compare all providers · Take the 60-second quiz
Partner link: we may earn a commission, at no extra cost to you.
In the trials that tested it, hormone therapy started around menopause neither improved nor harmed memory and thinking over the years studied, and in women who started it at 65 or older it increased the rate of dementia. The KEEPS trial randomized 693 women about a year and a half past their last period to oral conjugated estrogens, an estradiol patch or placebo for four years and found no treatment-related benefits on cognition; the oral estrogen group did report fewer depression and anxiety symptoms.
KEEPS-Cog (2015): "No treatment-related benefits were found on cognitive outcomes... MHT did not alter cognition as hypothesized."
ELITE (2016): estradiol "neither benefits nor harms these cognitive abilities regardless of time since menopause."
WHIMS (2003): "The hazard ratio for probable dementia was 2.05... This increased risk would result in an additional 23 cases of dementia per 10 000 women per year."
The Menopause Society (2022): hormone therapy "is not recommended at any age to prevent or treat decline in cognitive function or dementia."
The ELITE trial found that oral estradiol neither benefited nor harmed cognition whether it was started within six years of menopause or more than ten years after. The Women's Health Initiative Memory Study found that estrogen plus progestin in women aged 65 and older doubled the rate of probable dementia. That is why The Menopause Society's 2022 position statement says hormone therapy is not recommended at any age to prevent or treat decline in cognitive function or dementia.
HRT is prescribed for hot flashes, night sweats, genitourinary symptoms and bone protection, and the 2022 statement rates its benefit-risk balance as favorable for women under 60 or within ten years of menopause who have no contraindications. The brain is not on the list of reasons to take it.
Imaging studies led by Dr. Lisa Mosconi at Weill Cornell show measurable group-level differences in brain energy use, structure and connectivity across the menopause transition, and also show that much of it stabilizes afterward. A 2017 PET study of 43 cognitively normal women aged 40 to 60 found lower glucose metabolism in perimenopausal and postmenopausal women than in premenopausal women, in brain regions that are vulnerable in Alzheimer's disease, most pronounced after menopause.
Mosconi et al., 2021: "Brain biomarkers largely stabilized post-menopause, and gray matter volume (GMV) recovered in key brain regions for cognitive aging. Notably, GMV recovery and in vivo brain mitochondria ATP production correlated with preservation of cognitive performance post-menopause, suggesting adaptive compensatory processes."
A larger 2021 multimodal study found differences in gray matter volume, white matter, connectivity and energy metabolism across pre-, peri- and postmenopause that were specific to the hormonal transition rather than to age, by comparison with men of the same ages; the brain markers largely stabilized after menopause, gray matter volume recovered in key regions, and that recovery correlated with preserved cognitive performance, which the authors read as adaptive compensation. Amyloid-beta deposition was more pronounced in peri- and postmenopausal women who carry the APOE-4 gene variant than in men with the same genotype.
Estrogen receptors are found throughout the brain, including the hippocampus and prefrontal cortex, and the 2017 study was built on the finding, in animals, that estrogen regulates how the brain uses glucose. The imaging findings fit that biology. They are also small studies of cognitively normal women, comparing groups rather than diagnosing anyone, and the 2021 paper's own conclusion is that menopause is "a dynamic neurological transition," which is a different thing from damage.
Rarely, and the difference is checkable. Word-finding trouble, losing your thread and walking into rooms for no reason are common complaints across the transition, dementia is uncommon at the ages when menopause happens, and the imaging work above found that cognitive performance was preserved after menopause even as the brain reorganized. Two things warrant an evaluation rather than reassurance: cognitive change that is progressive and interferes with work or daily tasks, and change that other people notice before you do. A primary care clinician or neurologist can test memory formally, check thyroid function, B12, sleep and mood, and tell you where you stand. If you are in doubt, that visit is the answer, not this page.
Not as a direct effect on cognition, according to the trials: KEEPS found no cognitive benefit over four years, and ELITE found none whether estradiol was started early or late. What hormone therapy does reliably treat is hot flashes and night sweats, and the sleep disruption that comes with them. A woman who is woken four times a night by sweats and then cannot concentrate at work is not imagining the connection, and treating the sweats can change her days. That is a different claim from "estrogen improves memory," and the distinction matters when you are deciding whether to take a prescription drug. If brain fog is your main complaint and you have no hot flashes or sleep problems, the trial evidence does not support HRT as the answer, and a clinician should look for other causes first.
KEEPS Continuation (2024), an observational follow-up in which 275 of the original 693 women were re-tested about ten years after the trial: "there were no long-term cognitive effects of short-term exposure to mHT started in early menopause versus placebo... mHT does not improve or preserve cognitive function in this population."
No randomized trial has tested whether starting hormone therapy around menopause changes the chance of dementia decades later, the one large trial in older women found more dementia rather than less, and the observational studies point in both directions. The Cache County Study in Utah followed 1,768 women and reported that those who had used hormone therapy within five years of menopause had a 30 percent lower risk of Alzheimer's disease, while women who started opposed estrogen-progestin therapy later in life had a higher risk; its authors called the early-use result possibly beneficial and said it deserves further study.
Cache County (2012): "Although possibly beneficial if taken during a critical window near menopause, HT (especially opposed compounds) initiated in later life may be associated with increased risk. The relation of AD risk to timing and type of HT deserves further study."
Pourhadi et al., BMJ (2023): "Menopausal hormone therapy was positively associated with development of all cause dementia and Alzheimer's disease, even in women who received treatment at the age of 55 years or younger... Further studies are warranted to determine whether these findings represent an actual effect of menopausal hormone therapy on dementia risk, or whether they reflect an underlying predisposition in women in need of these treatments."
A 2023 Danish nationwide study of women aged 50 to 60 found the opposite: estrogen-progestogen therapy was associated with a 24 percent higher rate of all-cause dementia, rising with longer use, and the association held in women treated at 55 or younger and with as little as a year of use. Observational studies cannot settle causation in either direction, and the trials that exist measured cognition over a few years, not dementia over decades.
Start HRT online with Gala Health
Compare all providers · Take the 60-second quiz
Partner link: we may earn a commission, at no extra cost to you.
For heart and overall risk, timing is central to current guidance; for cognition, the trial built to test timing found no difference. The Menopause Society's position is that the benefit-risk ratio of hormone therapy is favorable for women under 60 or within ten years of menopause and less favorable after that, because of greater absolute risks of coronary heart disease, stroke, blood clots and dementia. The ELITE trial was designed to test the timing hypothesis for cognition specifically, comparing estradiol started within six years of menopause with estradiol started more than ten years after, and found that early initiation did not affect verbal memory, executive functions or global cognition differently from late initiation. So the honest summary is: start-early advice is about the safety of treating symptoms, not about protecting your brain.
The Alzheimer's Association reports that almost two-thirds of Americans living with Alzheimer's are women, and the reasons are not settled. Women live longer, and age is the largest risk factor, which explains part of the gap. Whether the menopause transition itself contributes is an active research question: the imaging studies above were designed around that hypothesis, and they show that the female brain goes through a distinct metabolic transition in midlife that men do not. What the research has not shown is that replacing estrogen reverses the risk; see the trial evidence above. It is reasonable to say that midlife matters for women's brain health. It is not yet reasonable to say that hormone therapy protects it.
The modifiable risk factors with evidence behind them, which the 2024 Lancet Commission on dementia prevention lists and which include physical inactivity, smoking, high blood pressure, diabetes, depression, social isolation and untreated hearing loss. In practice that means regular aerobic exercise and some strength work, blood pressure and blood sugar managed, hearing checked and corrected, alcohol kept moderate, and staying socially and mentally engaged. These are risk reductions across populations, not guarantees for any one person. Sleep is not on the Commission's list, but if night sweats or menopause-related insomnia are wrecking yours, treating them is worth doing for your days, which is a different reason from brain protection.
Menopause changes the brain in ways that show up on group-level imaging, brain fog is a common complaint across the transition, and for most women cognitive performance holds up as the brain adapts. Hormone therapy treats hot flashes, night sweats and the sleep they ruin; in the trials, it did not improve or protect memory in women who started it around menopause, and it raised dementia risk in women who started it at 65 or older. If symptoms are making your days hard, HRT is worth discussing with a clinician on its own merits. If lowering dementia risk is the goal, the evidence points at exercise, blood pressure, hearing and staying connected rather than at estrogen.
Find a clinician who treats menopause and can take a careful history before anyone reaches for a prescription.
Find a Provider Near YouStart HRT online with Gala Health
Get a licensed clinician, a prescription if HRT is right for you, and treatment shipped to your door - without an in-person visit.
Not sure which platform fits you? Take the 60-second match quiz or compare the best online HRT of 2026.
How getting started works
Share your health history
A short online questionnaire, about 5 minutes. No appointment and no waiting room.
A licensed clinician reviews
A licensed provider checks your history and, if HRT is right for you, writes the prescription.
Delivered to your door
Your treatment ships to you, usually within days, with ongoing check-ins and dose adjustments.
Some links above are partnerships. If you start care through them, we may earn a commission at no extra cost to you. Partners we can earn from may be shown first in some lists, but commission never changes the facts we report about any provider.
The old rule was 'lowest dose, shortest time.' That guidance has quietly been abandoned by most menopause specialists. Here is what the current evidence actually says about staying on hormone therapy long-term, why timing matters more than duration, and how to make the decision in partnership with a clinician who reads the literature.
Current US labels do not list menopausal HRT as a combination to avoid, but GLP-1 medicines slow stomach emptying, which raises questions for oral HRT. What the labels say, what the studies show, and what is still unknown.
The fear that HRT causes breast cancer has kept millions of women from treatment they might benefit from. But what does the current evidence actually say? We looked at the research so you don't have to.
Everything you need to know about HRT in one place - what it is, how it works, the different types, who it's for, and how to get started. Your comprehensive starting point.
Walking into a doctor's appointment can feel intimidating. Here are the questions that will help you get the most out of your visit and ensure your provider is the right fit.
The information on FindMyHRT is for educational and informational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment. Never disregard professional medical advice or delay seeking it because of something you have read on this website.
Everything you need before your first appointment, in one guide you can print:
Free. We'll email you the kit, then three short notes over the next ten days or so. Unsubscribe anytime. We never share your email.